ATE406437T1 - Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken - Google Patents

Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Info

Publication number
ATE406437T1
ATE406437T1 AT97938964T AT97938964T ATE406437T1 AT E406437 T1 ATE406437 T1 AT E406437T1 AT 97938964 T AT97938964 T AT 97938964T AT 97938964 T AT97938964 T AT 97938964T AT E406437 T1 ATE406437 T1 AT E406437T1
Authority
AT
Austria
Prior art keywords
antifungic
identifying
transferase activity
molecules acting
glucanosyl
Prior art date
Application number
AT97938964T
Other languages
English (en)
Inventor
Thierry Fontaine
Robbert Hartland
Isabelle Mouyna
Jean-Paul Latge
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE406437T1 publication Critical patent/ATE406437T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
    • H10D1/00—Resistors, capacitors or inductors
    • H10D1/01—Manufacture or treatment
    • H10D1/041—Manufacture or treatment of capacitors having no potential barriers
    • H10D1/043—Manufacture or treatment of capacitors having no potential barriers using patterning processes to form electrode extensions, e.g. etching
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
    • H10D1/00—Resistors, capacitors or inductors
    • H10D1/60—Capacitors
    • H10D1/68—Capacitors having no potential barriers
    • H10D1/692—Electrodes
    • H10D1/711—Electrodes having non-planar surfaces, e.g. formed by texturisation
    • H10D1/716—Electrodes having non-planar surfaces, e.g. formed by texturisation having vertical extensions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91091—Glycosyltransferases (2.4)
    • G01N2333/91097—Hexosyltransferases (general) (2.4.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10B—ELECTRONIC MEMORY DEVICES
    • H10B12/00—Dynamic random access memory [DRAM] devices
    • H10B12/01—Manufacture or treatment
    • H10B12/02—Manufacture or treatment for one transistor one-capacitor [1T-1C] memory cells
    • H10B12/03—Making the capacitor or connections thereto
    • H10B12/033—Making the capacitor or connections thereto the capacitor extending over the transistor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Magnetic Heads (AREA)
AT97938964T 1996-08-30 1997-08-29 Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken ATE406437T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2491096P 1996-08-30 1996-08-30

Publications (1)

Publication Number Publication Date
ATE406437T1 true ATE406437T1 (de) 2008-09-15

Family

ID=21822985

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938964T ATE406437T1 (de) 1996-08-30 1997-08-29 Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Country Status (8)

Country Link
US (5) US6551811B1 (de)
EP (1) EP0932665B1 (de)
JP (1) JP2001501814A (de)
AT (1) ATE406437T1 (de)
AU (1) AU4121997A (de)
DE (1) DE69738945D1 (de)
ES (1) ES2312178T3 (de)
WO (1) WO1998008937A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406437T1 (de) * 1996-08-30 2008-09-15 Pasteur Institut Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken
CA2486456C (en) * 2002-05-20 2012-07-17 Massachusetts Institute Of Technology Method for sequence determination using nmr
KR102144998B1 (ko) * 2013-08-30 2020-08-14 삼성전자주식회사 효모에 내산성을 부여하는 폴리펩티드, 그를 코딩하는 폴리뉴클레오티드, 그 양이 증가되어 있는 효모 세포, 상기 효모 세포를 이용한 산물의 생산 방법 및 내산성 효모 세포를 생산하는 방법
CN122404490A (zh) * 2026-06-17 2026-07-17 杭州认养一头牛生物科技有限公司 一种牛初乳粉经消化释放的免疫调节短肽及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406437T1 (de) * 1996-08-30 2008-09-15 Pasteur Institut Methode zur identifikation antifungischer moleküle, welche auf die glukanosyltransferaseaktivität wirken

Also Published As

Publication number Publication date
ES2312178T3 (es) 2009-02-16
DE69738945D1 (de) 2008-10-09
US7060454B2 (en) 2006-06-13
AU4121997A (en) 1998-03-19
JP2001501814A (ja) 2001-02-13
US6551811B1 (en) 2003-04-22
US20030147856A1 (en) 2003-08-07
US20060211013A1 (en) 2006-09-21
US7022495B2 (en) 2006-04-04
EP0932665A1 (de) 1999-08-04
WO1998008937A1 (fr) 1998-03-05
US20030152986A1 (en) 2003-08-14
EP0932665B1 (de) 2008-08-27
US5989895A (en) 1999-11-23

Similar Documents

Publication Publication Date Title
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
DE69023120D1 (de) Infusionssystem, methodologie und algorithmus zur identifizierung von patienten-induzierten druckartefakten.
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
WO1999036550A3 (en) Human protease molecules
ES8702431A1 (es) Procedimiento para preparar una proteina inhibidora de la coagulacion de la sangre
EP0655717A3 (de) Verkaufsstellensystem.
ATE328896T1 (de) Faktor viii vom schwein und hybriden
DE69828517D1 (de) Methode zur dns-isolierung.
DE3587989D1 (de) Vorrichtung zur Trennung der Proteine vom Blutplasma.
DE69434614D1 (de) Cdn apoptosis modulierende proteine, sie kodierende dns und verfahren zu ihrer verwendung
DE69428238D1 (de) Xylanase von einer Bacillus Spezies, Expressionsvektoren für diese Xylanase und andere Proteine, Wirtsorganismus dafür und Verwendungen davon
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
DE69532326D1 (de) Nukleinsäuresequenzen und expressionssysteme für heparinase iii aus flavobacterium heparinum
FI955431A0 (fi) Polyeetteripolyaminometyleenifosfonaatteja, jotka on tarkoitettu kattilakiven säätelyyn korkeassa pH:ssa
DE69637579D1 (de) Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
DE58904259D1 (de) Verfahren zur hydrierung von alfa, beta-ungesaettigten ketonen.
AU1855401A (en) Screening method for candidate drugs
BR9710919A (pt) Proteina purificada sr-p70
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
DE68914596D1 (de) Methode zur Gas-Flüssig-Kontaktierung.
DE69612006D1 (de) Methode zur gefässerweiterung mit (1,5-inter)arylprostaglandinderivaten
DE69532725D1 (de) Methode zur direkter klonierung von nukleasegenen in e.coli
DE59814032D1 (de) Nucleinsäuremolekül, kit und verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties